Trial Profile
Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2021
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 17 Feb 2021 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.
- 14 Jan 2020 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 12 May 2019 Status changed from active, no longer recruiting to completed, according to the results published in the Journal of Antimicrobial Chemotherapy